DLDominik H. W. Leitz

Dominik H. W. Leitz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dominik H. W. Leitz has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Julia Duerr

    Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany

    4 shared publications
  • Marcus Alexander Mall

    Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany

    4 shared publications
  • Hans-Ulrich Kauczor

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany

    3 shared publications
  • Mark Oliver Wielpütz

    Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany

    3 shared publications
  • Philip Konietzke

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany

    3 shared publications
  • Julia Duerr

    Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin (Germany). German Center for Lung Research (DZL), Associated Partner Site, Berlin, Germany

    2 shared publications

Latest Publications

  • Open Access

    Longitudinal microcomputed tomography detects onset and progression of pulmonary fibrosis in conditional Nedd4-2 deficient mice

    by Dominik H. W. Leitz, Philip Konietzke, Willi L. Wagner, Mara Mertiny, Claudia Benke, Thomas Schneider, Rory E. Morty, Christian Dullin, Wolfram Stiller, Hans-Ulrich Kauczor, et al.

    IPF diagnosis, particularly in early stages, remains challenging. In this study, micro-CT is used in conditional Nedd4-2−/− mice to closely monitor the onset and progression of progressive pulmonary fibrosis in vivo. Together with high-resolution post mortem micro-CT, this allowed us to track how nonspecific lung lesions develop into key IPF-like features. This approach offers a noninvasive method to monitor pulmonary fibrosis, providing a quantitative endpoint for the preclinical evaluation of novel antifibrotic strategies.


  • Open Access

    Characterization of transient and progressive pulmonary fibrosis by spatially correlated phase contrast microCT, classical histopathology and atomic force microscopy

    by Lorenzo D’aMico, Angelika Svetlove, Elena Longo, Ruth Meyer, Beatrice Senigagliesi, Giulia Saccomano, Philipp Nolte, Willi L. Wagner, Mark O. Wielpütz, Dominik H.W. Leitz, et al.


  • Microcomputed tomography to study the in vivo development of IPF-like disease in conditional Nedd4-2 deficient mice

    by Dominik Leitz, Philip Konietzke, Willi Wagner, Julia Duerr, Hans-Ulrich Kauczor, Marcus A. Mall, Mark O. Wielpütz

    Objective: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease which is usually diagnosed when irreversible lung damages already occurred. To date, little is known about the disease development before clinical manifestation. Recently, we developed a mouse model with conditional Nedd4-2 deficiency (Nedd4-2-/-) that produces a spontaneously progressive IPF-like disease which offers the opportunity for studies from the initiating event to terminal lung disease. Methods: We used in vivo and post mortem µCT imaging at different stages of IPF-like disease in conditional Nedd4-2-/- mice and applied a µCT based fibrosis score to quantify consolidations, honeycombing-like-lesions, fissural thickening, peripheral bronchiectasis, parenchymal lines, and reticulations. Further, we used in vivo longitudinal scans to study disease development in individual mice. Results: In vivo µCT imaging revealed the first fibrotic lesions 3 months after conditional Nedd4-2 deletion which further increasd in number and size the following months. In high resolution post mortem µCT scans, we found that unspecific interstitial alterations were detectable even at early stages of fibrotic lung disease, whereas IPF key features such as honeycombing-like-lesions develop late in disease progression. Conclusion: By µCT imaging, we were able to demonstrate the development of IPF key features in conditional Nedd4-2-/- mice and monitor disease progression of IPF like disease in vivo. Finally conditional Nedd4-2-/- mice are a valuable tool to investigate new diagnostic markers and evaluate new therapeutic strategies for IPF.

  • Open Access

    Longitudinal Micro-Computed Tomography Detects Onset and Progression of Pulmonary Fibrosis in Conditional Nedd4-2 Deficient Mice

    by Dominik H.W. Leitz, Philip Konietzke, Willi Wagner, Mara Mertiny, Claudia Benke, Thomas Schneider, Wolfram Stiller, Hans-Ulrich Kauczor, Marcus A. Mall, Julia Duerr, et al.

    Objectives: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease which is usually diagnosed late in advanced stages. Little is known about the subclinical development of IPF. We previously generated a mouse model with conditional Nedd4-2 deficiency ( Nedd4-2 −/− ) that develops IPF-like lung disease. The aim of this study was to characterize the onset and progression of IPF-like lung disease in conditional Nedd4-2 −/− mice by longitudinal micro- computed tomography (CT). Methods: In vivo micro-CT was performed longitudinally in control and conditional Nedd4- 2 −/− mice at 1, 2, 3, 4 and 5 months after doxycycline induction. Further, terminal in vivo micro-CT followed by pulmonary function testing and post mortem micro-CT was performed in age-matched mice. Micro-CT images were evaluated for pulmonary fibrosis using an adapted fibrosis scoring system. Results: Micro-CT is sensitive to detect onset and progression of pulmonary fibrosis in vivo and to quantify distinct radiological IPF-like features along disease development in conditional Nedd4-2 −/− mice. Nonspecific interstitial alterations were detected from 3 months, whereas key features such as honeycombing-like lesions were detected from 4 months onwards. Pulmonary function inversely correlated with in vivo (r=-0.725) and post mortem (r=-0.535) micro-CT fibrosis scores. Conclusion: Longitudinal micro-CT enables in vivo monitoring of onset and progression and detects radiologic key features of IPF-like lung disease in conditional Nedd4-2 −/− mice. Our data support micro-CT as sensitive quantitative endpoint for preclinical evaluation of novel antifibrotic strategies. NEW & NOTEWORTHY: IPF diagnosis, particularly in early stages, remains challenging. In this study micro-CT is used in conditional Nedd4-2 −/− mice to closely monitor the onset and progression of IPF-like lung disease. This allowed us to track for the first time how nonspecific lung lesions develop into key IPF-like features. This approach offers a non-invasive method to monitor pulmonary fibrosis in vivo , providing a quantitative endpoint for preclinical evaluation of novel antifibrotic strategies.

  • Open Access

    Linking Fibrotic Remodeling and Ultrastructural Alterations of Alveolar Epithelial Cells after Deletion of Nedd4-2

    by Theresa A. Engelmann, Lars Knudsen, Dominik H. W. Leitz, Julia Duerr, Michael F. Beers, Marcus A. Mall, Matthias Ochs

    Our previous study showed that in adult mice, conditional Nedd4-2-deficiency in club and alveolar epithelial type II (AE2) cells results in impaired mucociliary clearance, accumulation of Muc5b and progressive, terminal pulmonary fibrosis within 16 weeks. In the present study, we investigated ultrastructural alterations of the alveolar epithelium in relation to interstitial remodeling in alveolar septa as a function of disease progression. Two, eight and twelve weeks after induction of Nedd4-2 knockout, lungs were fixed and subjected to design-based stereological investigation at the light and electron microscopic level. Quantitative data did not show any abnormalities until 8 weeks compared to controls. At 12 weeks, however, volume of septal wall tissue increased while volume of acinar airspace and alveolar surface area significantly decreased. Volume and surface area of alveolar epithelial type I cells were reduced, which could not be compensated by a corresponding increase of AE2 cells. The volume of collagen fibrils in septal walls increased and was linked with an increase in blood–gas barrier thickness. A high correlation between parameters reflecting interstitial remodeling and abnormal AE2 cell ultrastructure could be established. Taken together, abnormal regeneration of the alveolar epithelium is correlated with interstitial septal wall remodeling.


  • Open Access

    Congenital Deletion of Nedd4-2 in Lung Epithelial Cells Causes Progressive Alveolitis and Pulmonary Fibrosis in Neonatal Mice

    by Dominik H. W. Leitz, Julia Duerr, Surafel Mulugeta, Ayça Seyhan Agircan, Stefan Zimmermann, Hiroshi Kawabe, Alexander H. Dalpke, Michael F. Beers, Marcus A. Mall

    Recent studies found that expression of NEDD4-2 is reduced in lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and that the conditional deletion of Nedd4-2 in lung epithelial cells causes IPF-like disease in adult mice via multiple defects, including dysregulation of the epithelial Na+ channel (ENaC), TGFβ signaling and the biosynthesis of surfactant protein-C proprotein (proSP-C). However, knowledge of the impact of congenital deletion of Nedd4-2 on the lung phenotype remains limited. In this study, we therefore determined the effects of congenital deletion of Nedd4-2 in the lung epithelial cells of neonatal doxycycline-induced triple transgenic Nedd4-2fl/fl/CCSP-rtTA2S-M2/LC1 mice, with a focus on clinical phenotype, survival, lung morphology, inflammation markers in BAL, mucin expression, ENaC function and proSP-C trafficking. We found that the congenital deletion of Nedd4-2 caused a rapidly progressive lung disease in neonatal mice that shares key features with interstitial lung diseases in children (chILD), including hypoxemia, growth failure, sterile pneumonitis, fibrotic lung remodeling and high mortality. The congenital deletion of Nedd4-2 in lung epithelial cells caused increased expression of Muc5b and mucus plugging of distal airways, increased ENaC activity and proSP-C mistrafficking. This model of congenital deletion of Nedd4-2 may support studies of the pathogenesis and preclinical development of therapies for chILD.